Status:
COMPLETED
Predictive Mini-bolus Fluid Responsiveness in Pediatric Septic Shock
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
URC-CIC Paris Descartes Necker Cochin
Conditions:
Severe Sepsis or Septic Shock in Pediatric Intensive Care Unit
Eligibility:
All Genders
28-15 years
Phase:
NA
Brief Summary
Severe sepsis and septic shock remain of particular gravity in children with a current mortality of about 20 % , despite the international prevention campaigns " survival sepsis campaign ". Septic sho...
Detailed Description
Severe sepsis and septic shock remain of particular gravity in children with a current mortality of about 20 % , despite the international prevention campaigns " survival sepsis campaign " . Septic sh...
Eligibility Criteria
Inclusion
- Baby (\>28 days) or children \< 15 years
- Hospitalisation in paediatric intensive
- Clinico-biological table compatible with severe sepsis or septic shock (likely or documented)
- Requiring the use of invasive mechanical ventilation
- Affiliate or beneficiary of a social security
- Legal guardians Consent Form or Emergency Procedure
Exclusion
- Any serious hemodynamic clinical situation that would be delayed by inclusion in the protocol
- Patient with shunt heart disease
- Patient in spontaneous or non-invasive ventilation or CPAP
- Patient with a contraindication to volemic/fluid expansion (major cardiac dysfunction, acute renal failure)
- Patient with cardiac arrest upper 5 min
- ECMO
- Postcardiotomia
Key Trial Info
Start Date :
February 23 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 20 2023
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT04027699
Start Date
February 23 2021
End Date
February 20 2023
Last Update
November 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Necker Enfants-Malades
Paris, France, 75015